Evidence map›Paper›PMID 30825711›Full record

ArticleNeuroImage. Clinical2019

Inter-rater agreement in glioma segmentations on longitudinal MRI.

M Visser, D M J Müller, R J M van Duijn, M Smits, N Verburg, E J Hendriks, R J A Nabuurs, J C J Bot, R S Eijgelaar, M Witte and 4 more

Abstract read
In one paragraph

Article in NeuroImage. Clinical, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Review
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

M VisserDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HZ Amsterdam, the Netherlands. Electronic address: m.visser2@vumc.nl.
D M J MüllerDepartment of Neurosurgery, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HZ Amsterdam, the Netherlands; Brain Tumor Center, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HZ Amsterdam, the Netherlands.
R J M van DuijnDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HZ Amsterdam, the Netherlands.
M SmitsDepartment of Radiology and Nuclear Medicine, Erasmus MC, PO Box 2040, 3000 CA Rotterdam, the Netherlands.
N VerburgDepartment of Neurosurgery, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HZ Amsterdam, the Netherlands; Brain Tumor Center, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HZ Amsterdam, the Netherlands.
E J HendriksDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HZ Amsterdam, the Netherlands.
R J A NabuursDepartment of Neurosurgery, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HZ Amsterdam, the Netherlands; Brain Tumor Center, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HZ Amsterdam, the Netherlands.
J C J BotDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HZ Amsterdam, the Netherlands.
R S EijgelaarDepartment of Radiotherapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1006 BE Amsterdam, the Netherlands.
M WitteDepartment of Radiotherapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1006 BE Amsterdam, the Netherlands.
M B van HerkInstitute of Cancer Sciences, Manchester Cancer Research Centre, Division of Cancer Science, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester M13 9PL, United Kingdom.
F BarkhofDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HZ Amsterdam, the Netherlands; Institutes of Neurology and Healthcare Engineering, University College London, Gower St, Bloomsbury, London WC1E 6BT, United Kingdom.
P C de Witt HamerDepartment of Neurosurgery, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HZ Amsterdam, the Netherlands.
J C de MunckDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HZ Amsterdam, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTumor segmentation of glioma on MRI is a technique to monitor, quantify and report disease progression. Manual MRI segmentation is the gold standard but very labor intensive. At present the quality of this gold standard is not known for different stages of the disease, and prior work has mainly focused on treatment-naive glioblastoma. In this paper we studied the inter-rater agreement of manual MRI segmentation of glioblastoma and WHO grade II-III glioma for novices and experts at three stages of disease. We also studied the impact of inter-observer variation on extent of resection and growth rate.

methodsIn 20 patients with WHO grade IV glioblastoma and 20 patients with WHO grade II-III glioma (defined as non-glioblastoma) both the enhancing and non-enhancing tumor elements were segmented on MRI, using specialized software, by four novices and four experts before surgery, after surgery and at time of tumor progression. We used the generalized conformity index (GCI) and the intra-class correlation coefficient (ICC) of tumor volume as main outcome measures for inter-rater agreement.

resultsFor glioblastoma, segmentations by experts and novices were comparable. The inter-rater agreement of enhancing tumor elements was excellent before surgery (GCI 0.79, ICC 0.99) poor after surgery (GCI 0.32, ICC 0.92), and good at progression (GCI 0.65, ICC 0.91). For non-glioblastoma, the inter-rater agreement was generally higher between experts than between novices. The inter-rater agreement was excellent between experts before surgery (GCI 0.77, ICC 0.92), was reasonable after surgery (GCI 0.48, ICC 0.84), and good at progression (GCI 0.60, ICC 0.80). The inter-rater agreement was good between novices before surgery (GCI 0.66, ICC 0.73), was poor after surgery (GCI 0.33, ICC 0.55), and poor at progression (GCI 0.36, ICC 0.73). Further analysis showed that the lower inter-rater agreement of segmentation on postoperative MRI could only partly be explained by the smaller volumes and fragmentation of residual tumor. The median interquartile range of extent of resection between raters was 8.3% and of growth rate was 0.22 mm/year.

conclusionManual tumor segmentations on MRI have reasonable agreement for use in spatial and volumetric analysis. Agreement in spatial overlap is of concern with segmentation after surgery for glioblastoma and with segmentation of non-glioblastoma by non-experts.

Indexed as

AdultAgedBrain NeoplasmsCohort StudiesFemaleGliomaHumansMagnetic Resonance ImagingMaleMiddle AgedNetherlandsObserver VariationRandom AllocationGlioblastomaGliomaInter-rater agreementLow-grade gliomaManual segmentationMRI

Identifiers

PMID30825711
PMCPMC6396436

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.